^
    Apply
    Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI (NCT04954599)
    Phase 1/2
    Maastricht University Medical Center
    Recruiting
    Last update posted :
    04/22/2024
    Initiation :
    04/25/2023
    Primary completion :
    02/01/2026
    Completion :
    05/01/2026
    BRCA1 • BRCA2
    |
    Keytruda (pembrolizumab) • Opdivo (nivolumab) • Tecentriq (atezolizumab) • Yervoy (ipilimumab) • carboplatin • Imfinzi (durvalumab) • Bavencio (avelumab) • Libtayo (cemiplimab-rwlc) • CP-506